Optimizing sedation in patients with acute brain injury

Area of Science:

• Critical Care Medicine
• Neuroscience
• Pharmacology

Background:

• Daily interruption of sedation and limited deep sedation improve outcomes in general ICU patients.
• Patients with severe acute brain injury (ABI) were excluded from prior trials, leaving the efficacy of minimal sedation in neuro-ICU (NICU) settings unclear.
• Sedation in ABI serves general and neuro-specific functions, including intracranial pressure management and seizure control.

Purpose of the Study:

• To review the cerebral physiologic effects of sedatives and analgesics.
• To compare standard sedatives (propofol, midazolam) with emerging alternatives like ketamine.
• To propose a pragmatic approach for sedation-analgesia in the NICU, considering ABI severity.

Main Methods:

• Literature review of randomized trials and existing studies on sedation in critically ill patients.
• Analysis of sedative agents' effects on cerebral and systemic hemodynamics.
• Discussion of titration and withdrawal strategies for sedation in the NICU.

Main Results:

• Evidence supports daily sedation interruption and limited deep sedation for general ICU patients.
• Specific data on minimal sedation efficacy and safety in ABI patients are lacking.
• Sedative selection in ABI must balance risks of intracranial pressure elevation against benefits of neurological improvement.

Conclusions:

• Translating general ICU sedation protocols to the NICU requires careful consideration of ABI-specific needs.
• A pragmatic approach to sedation-analgesia in NICU is needed, balancing risks and benefits.
• Optimal titration and withdrawal of sedation should be guided by ABI severity and neurophysiologic monitoring.